Long-Term Follow-Up Confirms a Sustained Reduction in Deaths from Prostate Cancer with PSA Screening By Ogkologos - November 4, 2025 338 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ERSPC study Source RELATED ARTICLESMORE FROM AUTHOR Immune-Modulating SBRT Plus Anti-PD-L1 May Convert Immune-Cold ER-positive, HER2-negative EBC Into More Inflamed Tumours and Improve Response EMA Recommends Extension of Therapeutic Indications for Serplulimab Benefit of Adjuvant Chemotherapy in Patients with ctDNA-positive Resected Stage II Colon Cancer MOST POPULAR Biweekly Cabazitaxel in Patients 65 Years or Older with mCRPC for... November 7, 2023 Boy Asks Mom Fighting Cancer To Take Off Her Turban So... May 4, 2020 Cancer Clinical Trials Bounce Back After Significant COVID-19 Disruption: Data From... June 15, 2022 ‘Inside Edition’ Anchor Thanks Viewer For Pointing Out Lump That Turned... April 24, 2019 Load more HOT NEWS Virchow: The Largest Foundation Model for Computational Pathology To Date Working to Close the Cancer Screening Gap Caused by COVID Patient Guide on Cancer Pain Management Now Available Also in French EMA Adopts a Positive Opinion for Biosimilar Denosumab
